Filing Details
- Accession Number:
- 0001567619-18-001171
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-08-15 15:14:07
- Reporting Period:
- 2018-08-13
- Accepted Time:
- 2018-08-15 15:14:07
- Original Submission Date:
- 2018-08-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447028 | Arbutus Biopharma Corp | ABUS | Pharmaceutical Preparations (2834) | 980597776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635324 | J. Michael Sofia | C/O Arbutus Biopharma Corp. Suite 100, 8900 Glenlyon Parkway Burnaby A1 V5J 5J8 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2018-08-13 | 4,250 | $9.51 | 167,162 | No | 4 | S | Indirect | Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 1,503,403 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.5073 to $9.5525, inclusive. The reporting person undertakes to provide to Arbutus Biopharma Corp., any security holder of Arbutus Biopharma Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
